Best deals to access real time data! |
|
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
|
|
DDE w/Realtime (Monthly)
Monthly Subscription
for only
|
|
Big Cap Pro
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| AbbVie Inc | ABBV | NYSE | Common Stock |
| Price Change | Change Percent | Stock Price | High Price | Low Price | Open Price | Close Price | Last Traded  |
|
|---|---|---|---|---|---|---|---|---|
| 0.18 | 0.24% | 73.81 | 73.99 | 73.39 | 73.74 | 73.63 | 10:20:20 |
| Stock Trades | Traded Volume | VWAP | Dollar Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 4,852 | 532,097 | $ 73.64 | $ 39,185,870 | 7,977,065 | 62.66 - 94.98 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 10:20:20 | 15 | $ 73.8141 | USD |
AbbVie Financials
| Market Cap | Shares in Issue | Profit/Loss | Earnings Per Share (EPS) | PE Ratio | Float |
|---|---|---|---|---|---|
| $ 108.79B | 1.48B | $ 5.69B | 3.68 | 25.60 | 1.48B |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| 54.26M | $ 3.59 | 4.88% | 10/11/19 | 13.00 | 0.10% |
AbbVie News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical ABBV Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol [m] | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 74.72 | 75.27 | 73.14 | 73.9012 | 6M | -0.91 | -1.22% |
| 1 Month | 70.55 | 76.4855 | 70.36 | 73.3490 | 8M | 3.26 | 4.62% |
| 3 Months | 68.5 | 76.4855 | 62.66 | 68.6500 | 9M | 5.31 | 7.75% |
| 6 Months | 80.83 | 81.75 | 62.66 | 71.1194 | 9M | -7.02 | -8.68% |
| 1 Year | 90.51 | 94.98 | 62.66 | 76.1542 | 7M | -16.7 | -18.45% |
| 3 Years | 61.45 | 125.86 | 55.0623 | 81.0130 | 6M | 12.36 | 20.11% |
| 5 Years | 53.62 | 125.86 | 45.45 | 71.4082 | 7M | 20.19 | 37.65% |
AbbVie Description
| AbbVie is a drug company with a strong exposure to immunology and oncology. The company's top drug, Humira, represents over half of the company's current profits. The company was spun off from Abbott in early 2013. |
